4//SEC Filing
Rometty Lisa Ann 4
Accession 0000950170-24-137318
CIK 0001856725other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:00 PM ET
Size
11.8 KB
Accession
0000950170-24-137318
Insider Transaction Report
Form 4
Rometty Lisa Ann
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-12-16−101,276→ 0 totalExercise: $2.84From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying) - Award
Stock Option (Right to Buy)
2024-12-16+17,708→ 49,037 totalExercise: $9.44Exp: 2032-01-02→ Class A Common Stock (17,708 underlying) - Award
Stock Option (Right to Buy)
2024-12-16+101,276→ 101,276 totalExercise: $4.11From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-16−17,708→ 0 totalExercise: $2.84Exp: 2032-01-02→ Class A Common Stock (17,708 underlying)
Footnotes (3)
- [F1]On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.
- [F2]The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years.
- [F3]On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001902958
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:00 PM ET
- Size
- 11.8 KB